Immunogenicity risk assessment for tailored mitigation and monitoring of biotherapeutics during development: recommendations from the European Immunogenicity Platform. - Grudzinska-Goebel J; Benstein K; Bloem K; Cowan KJ; Gorovits B; Jadhav M; Janssen M; Jawa V; Kiessling A; Kramer D; Kromminga A; van der Linden M; et al. (Frontiers in immunology, 2025)